Introducing pentavalent vaccine in EPI in India: Issues involved

Indian Journal of Medical Research

Volumn 132, Issue 10, 2010, Pages 450-453

  Jacob John, T ^a   Muliyil, Jayaprakash ^b  

^a NTAGI   (India)

^b CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE VACCINE; HAEMOPHILUS VACCINE; VACCINE;

HUMAN; IMMUNIZATION; INDIA; INNATE IMMUNITY; LETTER; MENINGITIS; PNEUMONIA; VACCINE PRODUCTION; BACTERIAL MEMBRANE; HAEMOPHILUS INFECTION; LEGAL ASPECT; MASS IMMUNIZATION; NOTE; STANDARD;

BACTERIAL CAPSULES; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS VACCINES; HEPATITIS B VACCINES; HUMANS; INDIA; MASS VACCINATION; VACCINES, COMBINED;

EID: 78049455539     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Letter

References (13)

1. Lone Z, Puliyel JM. Introducing pentavalent vaccine in the EPI in India: A counsel for caution. Indian J Med Res 2010; 132; 1-3.
2. John TJ. National Technical Advisory Group on Immunization: A major step forwards for child health. Indian Pediatr 2002; 39; 327-30.
3. John TJ. India's National Technical Advisory Group on Immunisation. Vaccine 2010; 28; A88-A90.
4. Subcommittee on introduction of Hib vaccine in Universal Immunization Programme, National Technical Advisory Group on Immunization, India. NTAGI subcommittee recommendations on Haemophilus influenzae type b vaccine introduction in India. Indian Pediatr 2009; 46; 945-54.
5. Verghese VP, Friberg IK, Cherian T, Raghupathy P, Balaji V, Lalitha MK, et al. Community effect of Haemophilus influenzae type b vaccination in India. Pediatr Infect Dis J 2009; 28; 738-40.
6. Registrar General of India, Centre for Global Health Research, St. Michael's Hospital, University of Toronto, Canada, Indian Council of Medical Research, India, St. John's Research Institute, School of Public Health, PGIMER. Million death study: Final report on causes of death in India 2001-2003, September 30, 2008. Available at: http://cghr.org/publications/Causes_of_death_2001-03_%20RGI_CGHR.pdf, accessed on July 22, 2010.
7. Gupta M, Kumar R, Deb AK, Bhattacharya SK, Bose A, John J, et al. A multi-centre surveillance for pneumonia and meningitis among children (<2 yr) for Hib vaccine probe trial preparation in India. Indian J Med Res 2010; 131; 649-58.
8. Adegbola RA, Secka O, Lahai G, Lloyd-Evans N, Njie A, Usen S, et al. Elimination of Haemophilus influenzae type b from the Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study. Lancet 2005; 366; 144-50.
9. Folb PI, Bernatowska E, Chen R, Clemens J, Dodoo AN, Ellenberg SS, et al. A global perspective on vaccine safety and public health: the Global Advisory Committee on Vaccine Safety. Am J Public Health 2004; 94; 1926-31.
10. Autran B, Asturias EJ, Evans S, Hartigan-go K, Hussey G, John TJ, et al. Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS. Expert Rev Vaccines 2009; 8; 705-16.
11. Dutta P, Puliyel JM. NTAGI recommendations overlooked crucial ICMR data. Indian Pediatr 2010; 47; 542-3.
12. Muliyil J, John TJ. NTAGI subcommittee recommendations did not overlook crucial data. Indian Pediatr 2010; 47; 721.
13. Lok Sabha Elections 2009. Manifesto of the Indian National Congress. Available at: http://aicc.org.in/new/manifesto09-eng.pdf, accessed on July 6, 2010.